Blinding Of Allocators

Blinding of Allocators is a methodological safeguard in clinical trial design that belongs to the category of allocation concealment techniques, distinguished by the deliberate withholding of information regarding upcoming treatment assignments from those responsible for enrolling participants, thereby preventing selection bias.

14

Publications

1.1K

Citations

50

Authors

25

Institutions

Publications per year

2017–2026

3

Authors

50

  1. DG
    Douglas G. Altman

    University of Oxford, United Kingdom

    2 publications · 175 citations

    2

    h-index

  2. RH
    Richard Hayes

    London School of Hygiene & Tropical Medicine, United Kingdom

    2 publications · 175 citations

    2

    h-index

  3. AB
    Alexandra Barratt

    The University of Sydney, Australia

    1 publications · 29 citations

    1

    h-index

  4. DH
    David H. Barlow

    Boston University, United States

    1 publications · 16 citations

    1

    h-index

  5. JP
    Jacqueline Pienaar

    University of Washington, United States

    1 publications · 11 citations

    1

    h-index

1–5 of 50

Venues

  1. Statistics in Medicine

    1 publications · 16 citations

    1

    h-index

  2. Controlled Clinical Trials

    1 publications · 14 citations

    1

    h-index

  3. Psychotherapy and Psychosomatics

    1 publications · 24 citations

    1

    h-index

  4. JAMA

    1 publications · 16 citations

    1

    h-index

  5. Trials

    1 publications · 48 citations

    1

    h-index

1–5